PLoS ONE (Jan 2017)

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.

  • Domingo Orozco-Beltran,
  • Vicente F Gil-Guillen,
  • Josep Redon,
  • Jose M Martin-Moreno,
  • Vicente Pallares-Carratala,
  • Jorge Navarro-Perez,
  • Francisco Valls-Roca,
  • Carlos Sanchis-Domenech,
  • Antonio Fernandez-Gimenez,
  • Ana Perez-Navarro,
  • Vicente Bertomeu-Martinez,
  • Vicente Bertomeu-Gonzalez,
  • Alberto Cordero,
  • Manuel Pascual de la Torre,
  • Jose L Trillo,
  • Concepcion Carratala-Munuera,
  • Salvador Pita-Fernandez,
  • Ruth Uso,
  • Ramon Durazo-Arvizu,
  • Richard Cooper,
  • Gines Sanz,
  • Jose M Castellano,
  • Juan F Ascaso,
  • Rafael Carmena,
  • Maria Tellez-Plaza,
  • ESCARVAL Study Group

DOI
https://doi.org/10.1371/journal.pone.0186196
Journal volume & issue
Vol. 12, no. 10
p. e0186196

Abstract

Read online

INTRODUCTIONThe potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with all-cause mortality and hospitalization due to cardiovascular events in a high-risk population.METHODSThis prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008-2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coronary heart disease or stroke. We estimated adjusted rate ratios (aRR), absolute risk differences and population attributable risk associated with adverse lipid profiles.RESULTS51,462 subjects were included with a mean age of 62.6 years (47.6% men). During an average follow-up of 3.2 years, 919 deaths, 1666 hospitalizations for coronary heart disease and 1510 hospitalizations for stroke were recorded. The parameters that showed an increased rate for total mortality, coronary heart disease and stroke hospitalization were, respectively, low HDL-Cholesterol: aRR 1.25, 1.29 and 1.23; high Total/HDL-Cholesterol: aRR 1.22, 1.38 and 1.25; and high Triglycerides/HDL-Cholesterol: aRR 1.21, 1.30, 1.09. The parameters that showed highest population attributable risk (%) were, respectively, low HDL-Cholesterol: 7.70, 11.42, 8.40; high Total/HDL-Cholesterol: 6.55, 12.47, 8.73; and high Triglycerides/HDL-Cholesterol: 8.94, 15.09, 6.92.CONCLUSIONSIn a population with cardiovascular risk factors, HDL-cholesterol, Total/HDL-cholesterol and triglycerides/HDL-cholesterol ratios were associated with a higher population attributable risk for cardiovascular disease compared to other common biomarkers.